Comments for BioBiz

Comment on BioBiz 2011 by Harry Teoh Jian Hung

Harry Teoh Jian Hung — Wed, 09 Mar 2011 14:31:20 +0000

i know already.

Comment on BioBiz 2010 by Wei Ting

Wei Ting — Sat, 27 Mar 2010 13:44:23 +0000

Thank you for the great conference today. =)

Comment on IP Protections? It is not only about patents! by Vicki

Vicki — Fri, 05 Jun 2009 09:57:47 +0000

Whether or not to go down the trade secrets or patents route is a perennial question that inventors face.

The obvious advantage of trade secrets over patents is that the protection continues indefinitely until the trade secret enters the public domain, as opposed to the 20-year patent term. The Coca-Cola recipe has remained a trade secret since possibly 1885. Also, there are no filing costs or regulatory compliance to speak of.

However, if a product risks being reverse engineered, patent protection is recommended. A patent registration confers upon the owner the right to prevent third parties from making commercial use of the patented product whereas trade secrets do not provide such a remedy.

Comment on Medical Technology Manufacturing in Singapore by smartguy

smartguy — Thu, 26 Mar 2009 01:30:46 +0000

hey YC, this section is for you to leave comments, but not to post queries.

Comment on When Science Versus Business, What Does It Mean? by GX

GX — Sat, 21 Mar 2009 17:14:06 +0000

With the Singapore government’s unilaterally goal of pushing the biomedical industry into the fourth pillar of the economy, it is now rightly so to encourage more bio-entrepreneurs to commercialize their discoveries. The scientific bigwigs we attracted over to head our institutions can teach us the science, but we need to acquire the business acumen ourselves.

Comment on “Publish or perish” Is it true? by yzlee

yzlee — Tue, 17 Mar 2009 02:50:09 +0000

The above comment is a reply from IPOS when I pose the question to them on their feedback channel.

Comment on “Publish or perish” Is it true? by yzlee

yzlee — Tue, 17 Mar 2009 02:48:47 +0000

it is apparent that in order for an intellectual creation to be protected under the laws of IP, the creation has to be more or less a tangible item such as an invention, a design or a trade mark. Thus, a theory when written down is protectable by copyright. However, the point to note is that the concept behind the theory is not protectable under any aspect of IP unless you consider it as a form of trade secret. Please note that even though the theory may not be protected, the by products of the theory may be protectable such as a book written based on the theory, there would be copyright protection of the book.

Comment on IP Protections? It is not only about patents! by yzlee

yzlee — Tue, 17 Mar 2009 02:45:14 +0000

Basically a smart company will always keep a record on the kind of Intellectual property that is being created in the course of its business. It does not matter who is responsible for creating the IP as the idea can come from someone in the frontline service or another staff from the back office. The important issue is that a company must have the means and systems in place to identify the IP that is being created so that proper protection can be attain for it to fully benefit the company.

Comment on HSA’s role in regulation of BMS in Singapore by yzlee

yzlee — Tue, 17 Mar 2009 02:33:23 +0000

When it comes to striking a balance between over regulation and under regulation, HSA embarks on means of smart regulation. HSA main focus of drug reviews are on drugs that have little or no regulation history. In addition, drugs that have gone through rigorous reviews by other regulatory bodies like the US FDA or the European Medicine Agency will have its own review by HSA accelerated.

To strengthen its regulatory capabilities, HSA have also come up with innovations that makes use of its extensive network to facilitate interactions with medical devices establishments and health care bodies. An example of this is the MEDICS@HSA system and the electronic medical record systems that HSA shares with the National Healthcare Group. This allows HSA to strengthen its surveillance capability and act swiftly on any issues.

Comment on Good news from GSK, but is it enough? by Liu Yuantai

Thu, 05 Mar 2009 06:01:48 +0000

true. a lot of block buster drugs are coming to the end of the patent. but i am still confident that the pharamceutical industry will emerge out of the crisis. after all this is an industry that is based on innovation, and knowledged-based and innovative industries tend to survive recessions better. thanks for the news zj:)http://biz.yahoo.com/ic/510.html